Skip to main navigation Skip to search Skip to main content

The OVAL Study: A Randomized, Controlled, Double-Arm, Open-Label, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs Paclitaxel Monotherapy for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/4/18 → 05/3/24

Funding

  • Vascular Biogenics Ltd: $179,548.33